Antheia Stock

antheia.bioBioTechFounded: 2013

Antheia is the developer of a novel whole-cell engineering approach to reconstruct complex molecules in yeast and a platform designed to enables the discovery and manufacturing of plant-inspired drugs of unprecedented complexity and diversity.

Register for Details

For more details on financing and valuation for Antheia, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Other companies like Antheia in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$186.12MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM